RETRACTED: Epitopes screening and vaccine molecular design of SADS-CoV based on immunoinformatics

Li, Shinian; Chen, Yaping

doi:10.3389/fvets.2022.1080927

ORIGINAL RESEARCH article

Front. Vet. Sci. , 02 March 2023

Sec. Veterinary Infectious Diseases

Volume 9 - 2022 | https://doi.org/10.3389/fvets.2022.1080927

This article is part of the Research Topic Advances in Swine Coronavirus: Genetic Character, Innate Immune Response, and Prevention View all 5 articles

RETRACTED: Epitopes screening and vaccine molecular design of SADS-CoV based on immunoinformatics

Retracted

A retraction of this article was approved in:

Retraction: Epitopes screening and vaccine molecular design of SADS-CoV based on immunoinformatics
1. Read retraction

$\nShinian Li&#x;$ Shinian Li^†

Yaping Chen^*

College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, Heilongjiang, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Li S and Chen Y (2023) Epitopes screening and vaccine molecular design of SADS-CoV based on immunoinformatics. Front. Vet. Sci. 9:1080927. doi: 10.3389/fvets.2022.1080927

Received: 26 October 2022; Accepted: 14 December 2022;
Published: 02 March 2023; Retracted: 29 November 2023.

Edited by:

Fangyu Wang, Henan Academy of Agricultural Sciences (HNAAS), China

Reviewed by:

Basavaraj S. Mathapati, Indian Council of Medical Research (ICMR), India
Ayat Tariq Zawawi, King Abdulaziz University, Saudi Arabia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

RETRACTED: Epitopes screening and vaccine molecular design of SADS-CoV based on immunoinformatics

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good